You are here: » News » Newsdetails:

News in Detail

Two Phase 2b Trials for Dry Eye Disease Show Positive Results

Oyster Point Pharma, Inc., today announced results from the ONSET and RAINIER studies, two separate Phase 2b clinical trials evaluating the company’s novel therapies for the treatment of Dry Eye Disease (DED).